Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Patritumab deruxtecan in untreated hormone receptor-positive/HER2-negative early breast cancer: final results from part A of the window-of-opportunity SOLTI TOT-HER3 pre-operative study.
Ann Oncol. 2023 Aug;34(8):670-680. doi: 10.1016/j.annonc.2023.05.004. Epub 2023 May 19.
Ann Oncol. 2023.
PMID: 37211044
Free article.
SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer.
Pascual T, Oliveira M, Ciruelos E, Bellet Ezquerra M, Saura C, Gavilá J, Pernas S, Muñoz M, Vidal MJ, Margelí Vila M, Cejalvo JM, González-Farré B, Espinosa-Bravo M, Cruz J, Salvador-Bofill FJ, Guerra JA, Luna Barrera AM, Arumi de Dios M, Esker S, Fan PD, Martínez-Sáez O, Villacampa G, Paré L, Ferrero-Cafiero JM, Villagrasa P, Prat A.
Pascual T, et al. Among authors: ferrero cafiero jm.
Front Oncol. 2021 Apr 23;11:638482. doi: 10.3389/fonc.2021.638482. eCollection 2021.
Front Oncol. 2021.
PMID: 33968735
Free PMC article.
Item in Clipboard
First-in-Human Randomized Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the KDM1A Inhibitor Vafidemstat.
Antonijoan RM, Ferrero-Cafiero JM, Coimbra J, Puntes M, Martínez-Colomer J, Arévalo MI, Mascaró C, Molinero C, Buesa C, Maes T.
Antonijoan RM, et al. Among authors: ferrero cafiero jm.
CNS Drugs. 2021 Mar;35(3):331-344. doi: 10.1007/s40263-021-00797-x. Epub 2021 Mar 23.
CNS Drugs. 2021.
PMID: 33755924
Free PMC article.
Clinical Trial.
Item in Clipboard
SOLTI-1503 PROMETEO TRIAL: combination of talimogene laherparepvec with atezolizumab in early breast cancer.
Pascual T, Cejalvo JM, Oliveira M, Vidal M, Vega E, Ganau S, Julve A, Zamora E, Miranda I, Delgado A, Bermejo B, la Cruz-Merino L, Juan M, Ferrero-Cafiero JM, Canes J, Gonzalez X, Villagrasa P, Prat A.
Pascual T, et al. Among authors: ferrero cafiero jm.
Future Oncol. 2020 Aug;16(24):1801-1813. doi: 10.2217/fon-2020-0246. Epub 2020 Jul 7.
Future Oncol. 2020.
PMID: 32633563
Item in Clipboard
Impact of Chiral Bioanalytical Methods on the Bioequivalence of Ibuprofen Products Containing Ibuprofen Lysinate and Ibuprofen Base.
García-Arieta A, Ferrero-Cafiero JM, Puntes M, Gich I, Morales-Alcelay S, Tarré M, Font X, Antonijoan RM.
García-Arieta A, et al. Among authors: ferrero cafiero jm.
Chirality. 2016 May;28(5):429-33. doi: 10.1002/chir.22598. Epub 2016 Apr 20.
Chirality. 2016.
PMID: 27094918
Clinical Trial.
Item in Clipboard
Ibuprofen lysinate, quicker and less variable: relative bioavailability compared to ibuprofen base in a pediatric suspension dosage form.
Ferrero-Cafiero JM, Gich I, Puntes M, Martínez J, Ballester MR, Coimbra J, Mathison Y, Tarré M, Font X, Antonijoan RM.
Ferrero-Cafiero JM, et al.
Int J Clin Pharmacol Ther. 2015 Nov;53(11):972-9. doi: 10.5414/CP202368.
Int J Clin Pharmacol Ther. 2015.
PMID: 26249766
Clinical Trial.
Item in Clipboard
Cite
Cite